These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 26183947)

  • 41. A pilot study to assess inflammatory biomarker changes when raltegravir is added to a virologically suppressive HAART regimen in HIV-1-infected patients with limited immunological responses.
    Lichtenstein KA; Armon C; Nagabhushanam V; Efaw BJ; Frazer-Abel A; Hiserote ME; Alam R
    Antivir Ther; 2012; 17(7):1301-9. PubMed ID: 22948290
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Novel method for detection of virus-specific CD41+ T cells indicates a decreased EBV-specific CD4+ T cell response in untreated HIV-infected subjects.
    Piriou ER; van Dort K; Nanlohy NM; van Oers MH; Miedema F; van Baarle D
    Eur J Immunol; 2005 Mar; 35(3):796-805. PubMed ID: 15724243
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antiretroviral therapy suppressed participants with low CD4+ T-cell counts segregate according to opposite immunological phenotypes.
    Pérez-Santiago J; Ouchi D; Urrea V; Carrillo J; Cabrera C; Villà-Freixa J; Puig J; Paredes R; Negredo E; Clotet B; Massanella M; Blanco J
    AIDS; 2016 Sep; 30(15):2275-87. PubMed ID: 27427875
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CD8+ T cells in HIV disease exhibit cytokine receptor perturbation and poor T cell receptor activation but are responsive to gamma-chain cytokine-driven proliferation.
    Pahwa R; McCloskey TW; Aroniadis OC; Strbo N; Krishnan S; Pahwa S
    J Infect Dis; 2006 Mar; 193(6):879-87. PubMed ID: 16479523
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increased proliferation within T lymphocyte subsets of HIV-infected adolescents.
    Starr SE; Sarr M; Campbell DE; Wilson CM; Douglas SD
    AIDS Res Hum Retroviruses; 2002 Nov; 18(17):1301-10. PubMed ID: 12487818
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Altered clonogenic capability and stromal cell function characterize bone marrow of HIV-infected subjects with low CD4+ T cell counts despite viral suppression during HAART.
    Isgrò A; Leti W; De Santis W; Marziali M; Esposito A; Fimiani C; Luzi G; Pinti M; Cossarizza A; Aiuti F; Mezzaroma I
    Clin Infect Dis; 2008 Jun; 46(12):1902-10. PubMed ID: 18462177
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Changes in cellular immune activation and memory T-cell subsets in HIV-infected Zambian children receiving HAART.
    Rainwater-Lovett K; Nkamba H; Mubiana-Mbewe M; Moore CB; Margolick J; Moss WJ
    J Acquir Immune Defic Syndr; 2014 Dec; 67(5):455-62. PubMed ID: 25226208
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The proportion of CD57+ cells among effector CD8+ T cells is lower in HIV controllers compared with antiretroviral therapy-treated patients.
    Henriquez S; Lécuroux C; Bitu M; Avettand-Fenoel V; Churaqui F; Catalan P; Chéret A; Boufassa F; Saez-Cirion A; Monceaux V; Meyer L; Goujard C; Lambotte O; Bourgeois C;
    AIDS; 2019 Nov; 33(14):2137-2147. PubMed ID: 31688039
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increased frequencies of Th17 cells and IL17a-producing regulatory T-cells preceding the immunodiscordant response to antiretroviral treatment.
    Rosado-Sánchez I; Herrero-Fernández I; Tarancon-Diez L; Moreno S; Iribarren JA; Dalmau D; Vera-Méndez F; Leal M; Pacheco YM
    J Infect; 2018 Jan; 76(1):86-92. PubMed ID: 29079322
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Induction of prolonged survival of CD4+ T lymphocytes by intermittent IL-2 therapy in HIV-infected patients.
    Kovacs JA; Lempicki RA; Sidorov IA; Adelsberger JW; Sereti I; Sachau W; Kelly G; Metcalf JA; Davey RT; Falloon J; Polis MA; Tavel J; Stevens R; Lambert L; Hosack DA; Bosche M; Issaq HJ; Fox SD; Leitman S; Baseler MW; Masur H; Di Mascio M; Dimitrov DS; Lane HC
    J Clin Invest; 2005 Aug; 115(8):2139-48. PubMed ID: 16025158
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Loss of CD127 & increased immunosenescence of T cell subsets in HIV infected individuals.
    Mojumdar K; Vajpayee M; Chauhan NK; Singh A; Singh R; Kurapati S
    Indian J Med Res; 2011 Dec; 134(6):972-81. PubMed ID: 22310831
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A transcriptome-based model of central memory CD4 T cell death in HIV infection.
    Olvera-García G; Aguilar-García T; Gutiérrez-Jasso F; Imaz-Rosshandler I; Rangel-Escareño C; Orozco L; Aguilar-Delfín I; Vázquez-Pérez JA; Zúñiga J; Pérez-Patrigeon S; Espinosa E
    BMC Genomics; 2016 Nov; 17(1):956. PubMed ID: 27875993
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Depletion of naive CD4 T cells by CXCR4-using HIV-1 variants occurs mainly through increased T-cell death and activation.
    Hazenberg MD; Otto SA; Hamann D; Roos MT; Schuitemaker H; de Boer RJ; Miedema F
    AIDS; 2003 Jul; 17(10):1419-24. PubMed ID: 12824778
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of Heavy Drinking on T-Cell Phenotypes Consistent with Immunosenescence in Untreated HIV Infection.
    So-Armah KA; Edelman EJ; Cheng DM; Doyle MF; Patts GJ; Gnatienko N; Krupitsky EM; Samet JH; Freiberg MS
    Alcohol Clin Exp Res; 2016 Aug; 40(8):1737-43. PubMed ID: 27388907
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vivo dynamics of T cell activation, proliferation, and death in HIV-1 infection: why are CD4+ but not CD8+ T cells depleted?
    Ribeiro RM; Mohri H; Ho DD; Perelson AS
    Proc Natl Acad Sci U S A; 2002 Nov; 99(24):15572-7. PubMed ID: 12434018
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pathological Role of Anti-CD4 Antibodies in HIV-Infected Immunologic Nonresponders Receiving Virus-Suppressive Antiretroviral Therapy.
    Luo Z; Li Z; Martin L; Wan Z; Meissner EG; Espinosa E; Wu H; Yu X; Fu P; Julia Westerink MA; Kilby JM; Wu J; Huang L; Heath SL; Li Z; Jiang W
    J Infect Dis; 2017 Jul; 216(1):82-91. PubMed ID: 28498953
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Increased homeostatic cytokines and stability of HIV-infected memory CD4 T-cells identify individuals with suboptimal CD4 T-cell recovery on-ART.
    Pino M; Pereira Ribeiro S; Pagliuzza A; Ghneim K; Khan A; Ryan E; Harper JL; King CT; Welbourn S; Micci L; Aldrete S; Delman KA; Stuart T; Lowe M; Brenchley JM; Derdeyn CA; Easley K; Sekaly RP; Chomont N; Paiardini M; Marconi VC
    PLoS Pathog; 2021 Aug; 17(8):e1009825. PubMed ID: 34449812
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Central memory CD4+ T cell responses in chronic HIV infection are not restored by antiretroviral therapy.
    Elrefaei M; McElroy MD; Preas CP; Hoh R; Deeks S; Martin J; Cao H
    J Immunol; 2004 Aug; 173(3):2184-9. PubMed ID: 15265956
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Direct visualization of cytokine-producing recall antigen-specific CD4 memory T cells in healthy individuals and HIV patients.
    Helms T; Boehm BO; Asaad RJ; Trezza RP; Lehmann PV; Tary-Lehmann M
    J Immunol; 2000 Apr; 164(7):3723-32. PubMed ID: 10725731
    [TBL] [Abstract][Full Text] [Related]  

  • 60. HIV-DNA content in different CD4+ T-cell subsets correlates with CD4+ cell :  CD8+ cell ratio or length of efficient treatment.
    Gibellini L; Pecorini S; De Biasi S; Bianchini E; Digaetano M; Pinti M; Carnevale G; Borghi V; Guaraldi G; Mussini C; Cossarizza A; Nasi M
    AIDS; 2017 Jun; 31(10):1387-1392. PubMed ID: 28426533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.